Compare STAG & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STAG | TXG |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.5B |
| IPO Year | 2010 | 2019 |
| Metric | STAG | TXG |
|---|---|---|
| Price | $35.64 | $88.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 19 |
| Target Price | $41.75 | ★ $58.80 |
| AVG Volume (30 Days) | 1.3M | ★ 2.6M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.36% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $845,184,000.00 | $245,893,000.00 |
| Revenue This Year | $7.53 | N/A |
| Revenue Next Year | $7.24 | $9.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 10.14 | ★ 68.06 |
| 52 Week Low | $35.55 | $11.17 |
| 52 Week High | $42.61 | $94.54 |
| Indicator | STAG | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 34.11 | 78.04 |
| Support Level | N/A | $74.60 |
| Resistance Level | $38.21 | N/A |
| Average True Range (ATR) | 0.59 | 5.41 |
| MACD | -0.14 | 1.13 |
| Stochastic Oscillator | 0.82 | 88.85 |
Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).